FSD Pharma receives regulatory clearance for proposed Phase 1 clinical trial of multiple sclerosis drug candidate Lucid-MSProactive Investors • 02/07/23
Lucid stock pulls back in active trading after a record rally in the previous sessionMarket Watch • 01/30/23